Learning Hub Central

Clinical Trials

← Back to Specialities

2025 CCC | Optimizing Early Phase Trial Designs

2025 CCC | Optimizing Early Phase Trial Designs

Clinical Trials

Non-CME Credit Course

Overview on How to Submit a Clinical Letter of Intent (LOI) to NCI/CTEP

Overview on How to Submit a Clinical Letter of Intent (LOI) to NCI/CTEP

Clinical Trials

Non-CME Credit Course

Expansion Cohorts in Early Phase Clinical Trials: Valuable or Not?

Expansion Cohorts in Early Phase Clinical Trials: Valuable or Not?

Clinical Trials

Non-CME Credit Course

What’s After PACIFIC? Can We Raise the Bar?

What’s After PACIFIC? Can We Raise the Bar?

Clinical Trials

Non-CME Credit Course

2023 CCC | The Future of Developmental Therapeutics in Oncology

2023 CCC | The Future of Developmental Therapeutics in Oncology

Clinical Trials

Non-CME Credit Course

2023 CCC | Translating Pre-Clinical Studies to NCI-CTEP Clinical Trials

2023 CCC | Translating Pre-Clinical Studies to NCI-CTEP Clinical Trials

Clinical Trials

Non-CME Credit Course

2023 CCC | Novel Trial Designs for Early Phase Clinical Trials: Beyond 3+3

2023 CCC | Novel Trial Designs for Early Phase Clinical Trials: Beyond 3+3

Clinical Trials

Non-CME Credit Course

2023 CCC | Project Optimus and Optimizing Dose and Schedule in Early Phase Clinical Trials

2023 CCC | Project Optimus and Optimizing Dose and Schedule in Early Phase Clinical Trials

Clinical Trials

Non-CME Credit Course

Stage IIIA-B-C NSCLC: Does The PACIFIC Data Fit All-in-One?

Stage IIIA-B-C NSCLC: Does The PACIFIC Data Fit All-in-One?

Clinical Trials

Non-CME Credit Course

Statistical Considerations in Early Phase Clinical Trial Design in the Era of Targeted Therapy and Immunotherapy

Statistical Considerations in Early Phase Clinical Trial Design in the Era of Targeted Therapy and Immunotherapy

Clinical Trials

Non-CME Credit Course

Translating Clinical Trials' Results into Clinical Practice

Translating Clinical Trials' Results into Clinical Practice

Clinical Trials

Non-CME Credit Course

Integrating Biomarkers into Targeted Therapy and Immunotherapy Clinical Trials

Integrating Biomarkers into Targeted Therapy and Immunotherapy Clinical Trials

Clinical Trials

Non-CME Credit Course

Phase I Trials: Whats New in 2019?

Phase I Trials: Whats New in 2019?

Clinical Trials

Non-CME Credit Course

From Bench to Bedside (and Back): Early Clinical Trials

From Bench to Bedside (and Back): Early Clinical Trials

Clinical Trials

Non-CME Credit Course

Panel_ Translating Clinical Trials' Results into Clinical Practice

Panel_ Translating Clinical Trials' Results into Clinical Practice

Clinical Trials

Non-CME Credit Course

Phase 1 Trials What’s New in 2019

Phase 1 Trials What’s New in 2019

Clinical Trials

Non-CME Credit Course

A Vision for Optimizing Patient Outcomes

A Vision for Optimizing Patient Outcomes

Clinical Trials

Non-CME Credit Course

Understanding Multi-Cohort Trials

Understanding Multi-Cohort Trials

Clinical Trials

Non-CME Credit Course

Clinical Trials 101

Clinical Trials 101

Clinical Trials

Non-CME Credit Course

Phase 1 Exp Cohorts vs Phase 2 Trials

Phase 1 Exp Cohorts vs Phase 2 Trials

Clinical Trials

Non-CME Credit Course

Modern Clinical Trial Design, Pharmacology and Drug Development

Modern Clinical Trial Design, Pharmacology and Drug Development

Clinical Trials

Non-CME Credit Course

Current Epidemiology and Incidence of Esophageal Cancer: East vs West; Implications on Clinical Trials

Current Epidemiology and Incidence of Esophageal Cancer: East vs West; Implications on Clinical Trials

Clinical Trials

Non-CME Credit Course

Innovative Early Phase Clinical Trial Designs

Innovative Early Phase Clinical Trial Designs

Clinical Trials

Non-CME Credit Course

Contact Us

info@meccinc.com

© 2025 MEC Inc. All rights reserved

Powered By CMEGenius™

Privacy Policy Terms and Conditions Cancellation & Refund Policy